Table 3 Incidence of development of RA, OA, and OA with joint replacement after truncal vagotomy versus superselective vagotomy
From: Vagotomy and the incidence of rheumatoid arthritis and osteoarthritis: a Danish register-based study
Truncal Vagotomy Cohort (n = 2260) | Superselective Vagotomy Cohort (n = 3810) | |
|---|---|---|
Incident RA, n* (%) | 10 (0.7) | 10 (0.3) |
IR (95% CI) for RA | 10.2 (6.5–15.3) | 12.1 (8.8–16.1) |
Crude HR (95% CI) for RA | 3.68 (1.54–8.78) | 1.0 |
Adjusted HR (95% CI)* for RA | 3.08 (1.22–7.79) | 1.0 |
Incident OA, n* (%) | 30 (1.3) | 30 (0.8) |
IR (95% CI) for OA | 46.9 (38.4–56.7) | 85.9 (76.8–95.7) |
Crude HR (95% CI) for OA | 2.16 (1.32–3.53) | 1.0 |
Adjusted HR (95% CI)* for OA | 1.12 (0.64–1.94) | 1.0 |
Incident OA w/JR, n* (%) | 10 (0.4) | 10 (0.3) |
IR (95% CI) for OA w/JR | 25.7 (19.5–33.2) | 50.4 (43.5–58.1) |
Crude HR (95% CI) for OA w/JR | 2.24 (0.84–5.97) | 1.0 |
Adjusted HR (95% CI)* for OA w/JR | 0.61 (0.19–1.90) | 1.0 |